The stock of Cutera Inc (NASDAQ:CUTR) last traded at $2.02, up 4.12% from the previous session.
Data from the available sources indicates that Cutera Inc (NASDAQ:CUTR) is covered by 5 analysts. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $10.00 and a low of $3.00, we find $10.00. Given the previous closing price of $1.94, this indicates a potential upside of 415.46 percent. CUTR stock price is now -55.64% away from the 50-day moving average and -87.56% away from the 200-day moving average. The market capitalization of the company currently stands at $40.28M.
In total, 2 analysts have assigned it a hold rating, and 2 have given it a buy rating. Brokers who have rated the stock have averaged $7.67 as their price target over the next twelve months.
With the price target enhanced from $14 to $18, Piper Sandler Upgraded its rating from Underweight to Neutral for Cutera Inc (NASDAQ: CUTR).
In other news, Harris Taylor C., Chief Executive Officer bought 30,000 shares of the company’s stock on Aug 29. The stock was bought for $297,300 at an average price of $9.91. Upon completion of the transaction, the Chief Executive Officer now directly owns 279,336 shares in the company, valued at $0.56 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 29, Interim CFO Drummond Stuart bought 5,000 shares of the business’s stock. A total of $49,000 was incurred on buying the stock at an average price of $9.80. This leaves the insider owning 19,678 shares of the company worth $39749.56. Insiders disposed of 26,283 shares of company stock worth roughly $53091.66 over the past 1 year. A total of 8.65% of the company’s stock is owned by insiders.
With an opening price of $1.9800 on Wednesday morning, Cutera Inc (NASDAQ: CUTR) set off the trading day. During the past 12 months, Cutera Inc has had a low of $1.38 and a high of $52.89. The fifty day moving average price for CUTR is $4.5540 and a two-hundred day moving average price translates $16.2421 for the stock.
The latest earnings results from Cutera Inc (NASDAQ: CUTR) was released for Jun, 2023. According to the Medical Devices Company, earnings per share came in at -$0.69, missing analysts’ expectations of -$0.63 by -0.06. This compares to -$2.53 EPS in the same period last year. The net profit margin was -33.29% and return on equity was -4447.26% for CUTR. The company reported revenue of $61.22 million for the quarter, compared to $64.22 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -4.68 percent. For the current quarter, analysts expect CUTR to generate $49.18M in revenue.
Cutera Inc(CUTR) Company Profile
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all body and skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and enlighten, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides excel HR, a hair removal solution for all skin types; and xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
